Aequus Pharmaceuticals Inc.
AQSZF
$0.0039
$0.000.00%
AQSZF market cap represents
0.00%
of the sector.
Valuation
AQSZF
Low
AQSZF
Sector Average
High
Market Cap
699.45K
< 699.45K
> 15.90B
Enterprise Value
5.02M
< 0.00
> 18.12B
Price/Earnings (TTM)
-0.26
< -10.00
> 10.00
Earnings Per Share Growth (TTM)
-18.13%
< -70.00%
> -10.00%
Price/Earnings To Growth (TTM)
--
0.00
11.91
Price/Sales (TTM)
1.77
< 0.000
> 440.00
Price/Book (Q)
-0.11
< -10.00
> 20.00
Enterprise Value/Revenue (TTM)
16.47
< 10.00
> 200.00
Enterprise Value/EBITDA (TTM)
-2.74
< -10.00
> 10.00
Enterprise Value/EBIT (TTM)
-2.73
< -10.00
> 10.00
Dividends and Shares
AQSZF
Low
AQSZF
Sector Average
High
Shares Outstanding
132.63M
< 60.00M
> 250.00M
Dividend Per Share (Most Recent)
--
0.00
2.38
Dividend Per Share (TTM)
--
0.00
9.13
Dividend Yield (TTM)
--
0.00%
8.58%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
AQSZF
Low
AQSZF
Sector Average
High
Beta
-0.24
< -10.00
4.98
1-Month Total Return
-17.72%
< -30.00%
> 0.00%
3-Month Total Return
0.00%
< -50.00%
> 0.00%
6-Month Total Return
-53.57%
< -60.00%
> 0.00%
Year to Date Total Return
0.00%
< -40.00%
> 0.00%
1-Year Total Return
-69.24%
< -70.00%
> 0.00%
2-Year Total Return
-83.75%
< -90.00%
> 20.00%
3-Year Total Return
-93.95%
-100.00%
> 0.00%
5-Year Total Return
-95.30%
-100.00%
> 150.00%
Profitability
AQSZF
Low
AQSZF
Sector Average
High
Operating Margin (TTM)
-602.87%
< -14,860.00%
> -600.00%
Profit Margin (TTM)
-649.02%
< -11,260.00%
> -640.00%
Management Effectiveness
AQSZF
Low
AQSZF
Sector Average
High
Return on Assets (TTM)
-152.14%
< -160.00%
> -10.00%
Return on Equity (TTM)
--
0.26%
1,905.92%
Income Statement
AQSZF
Low
AQSZF
Sector Average
High
Revenue (TTM)
303.10K
< 0.00
> 12.68B
Total Revenue (TTM)
303.10K
< 0.00
> 12.92B
Total Revenue Growth (Q YOY)
987.00%
< 400.00%
> 1,610.00%
Revenue Per Share (TTM)
0.00
< 0.00
> 190.00
Gross Profit (TTM)
162.20K
< 0.00
> 3.81B
EBITDA (TTM)
-1.82M
< -10.00M
> 1.15B
EBIT (TTM)
-1.83M
< -10.00M
> 780.00M
Net Income (TTM)
-1.97M
< -10.00M
> 300.00M
Net Income Avl. to Common (TTM)
-1.97M
< -10.00M
> 300.00M
Earnings Growth (Q YOY)
24.78%
< -150.00%
> 30.00%
EPS Diluted (TTM)
-0.01
< -4,610.00
> 0.00
EPS Diluted Growth (Q YOY)
24.44%
< 20.00%
> 90.00%
Balance Sheet
AQSZF
Low
AQSZF
Sector Average
High
Cash and Short-Term Inv. (Q)
18.80K
11.00K
> 1.44B
Cash Per Share (Q)
0.00
0.00
> 210.00
Total Current Assets (Q)
227.00K
18.60K
> 3.65B
Total Assets (Q)
635.10K
302.20K
> 10.33B
Total Current Liabilities (Q)
4.88M
110.30K
> 2.72B
Total Debt (Q)
4.84M
0.00
> 3.32B
Total Liabilities (Q)
5.24M
117.90K
> 6.49B
Total Common Equity (Q)
-4.60M
< -10.00M
> 3.74B
Total Preferred Equity (Q)
--
0.00
920.42M
Total Equity (Q)
-4.60M
< -10.00M
> 3.84B
Current Ratio (Q)
0.047
0.086
> 20.000
Book Value Per Share (Q)
-0.03
< -10.00
> 1,210.00
Cash Flow
AQSZF
Low
AQSZF
Sector Average
High
Cash from Operations (TTM)
-1.82M
< -10.00M
> 760.00M
Cash from Investing (TTM)
--
-21.35B
3.43B
Cash from Financing (TTM)
1.76M
< -190.00M
> 10.00M
Net Change in Cash (TTM)
-62.30K
< -30.00M
> 0.00
Levered Free Cash Flow (TTM)
-1.15M
< -10.00M
> 570.00M
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the sector.
